Summary
We recently described culture conditions that allow proliferation of metastatic human breast cancer cells from biopsy specimens of certain patient samples. These conditions resulted in the development of an immortalized cell strain designated SUM-44PE. These same culture conditions were used to isolate a human breast cancer cell strain from a metastatic lymph node of a separate breast cancer patient. The SUM-16LN human breast cancer cells isolated from this specimen were cultured either in serum-free medium or serum-containing medium supplemented with insulin and hydrocortisone. Unlike the SUM-44PE cells that have proliferated in culture continuously for over two years, SUM-16LN cells proliferated in culture for approximately 200 days and underwent 15 to 20 population doublings before undergoing cell senescence. No cells of this strain proliferated beyond passage 8. SUM-16LN cells were keratin-19 positive and had an aneuploid karyotype. These cells overexpressed p53 protein and had an amplified epidermal growth factor (EGF) receptor gene that resulted in high level expression of tyrosine phosphorylated EGF receptor protein. Despite the presence of high levels of tyrosine phosphorylated EGF receptor in these cells, they proliferated in serum-free, EGF-free medium and did not secrete detectable levels of EGF-like mitogenic growth factor. In addition, these cells were potently growth inhibited by all concentrations of exogenous EGF tested and by the neutralizing EGF receptor antibody Mab 425. These results suggest that the high level of tyrosine phosphorylated EGF receptor present in these cells is the direct result of receptor overexpression and not the result of the presence of a simulatory ligand. Thus, SUM-16LN represents a human breast cancer cell strain that exhibited genetic and cellular characteristics of advanced human breast cancer cells. Nevertheless, these cells exhibited a finite proliferative lifespan in culture, suggesting that cellular immortalization is not a phenotype expressed by all human breast cancer cells.
References
Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR: Clonal proliferation of cultured nonmalignant human breast epithelia. Cancer Res 41: 4637–4643, 1981
Petersen OW, van Deurs B: Preservation of defined phenotypic traits in short-term cultured human breast carcinoma derived epithelial cells. Cancer Res 47: 856–866, 1987
Band V, Sager R: Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86: 1249–1253, 1989
Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R, Trent J: Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer 63: 727–735, 1991
Ethier SP, Summerfelt RM, Cundiff KC, Asch BB: The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat 17: 221–230, 1990
Ethier SP, Mahacek ML, Gullick WJ, Frank TJ, Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 53: 627–635, 1993
Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585–621, 1961
Newbold RR, Overell RW: Fibroblast immortality is a prerequisite for transformation of EJ c-Ha-ras oncogene. Nature 304: 648–651, 1983
Lechner JF, Jaugen A, McClendon IA, Pettis WE: Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. In Vitro 18: 633–642, 1982
Ethier SP, Cundiff KC: Importance of extended growth potential and growth factor independence onin vivo neoplastic potential of primary rat mammary carcinoma cells. Cancer Res 47: 5316–5322, 1987
Smith HS, Wolman SR, Dairkee SH, Hancock MC, Lippman M, Leff A, Hackett AJ: Immortalization in culture: Occurrence at a late stage in the progression of breast cancer. J Natl Cancer Inst 78: 611–615, 1987
Ethier SP, Kudla A, Cundiff KC: The influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cellsin vitro. J Cell Physiol 132: 161–167, 1987
Butler WB: Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal Biochem 141: 70–73, 1984
Kovach JS, Mcgovern RM, Cassady JD, Swanson SK, Wold LE, Vogelstein B, Sommer SS: Direct sequencing from touch preparations of human carcinomas - analysis of p53 mutations in breast carcinomas. J Nat Cancer Inst 83: 1004–1009, 1991
Ethier SP, Moorthy R, Dilts CA: Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth Diff 2: 593–602, 1991
Frye RA, Benz CC, Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4: 1153–1157, 1989
Neubauer A, Neubauer B, He M, Effert P, Iglehart D, Frye RA, Liu E: Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 7: 1019–1025, 1992
Al-Kasspooles M, Moore JH, Orringer MB, Beer D: Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 54: 1–7, 1993
Ethier SP: Serum-free culture conditions for the growth of normal rat mammary epithelial cells in primary culture. In Vitro: Cell Dev Biol 22: 485–490, 1986
Petersen OW, van Deurs B, Nielsen KV, Madsen MW, Laursen I, Balslev I, Briand P: Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium. Cancer Res 50: 1257–1270, 1990
Schlessinger J: Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 103: 2067–2072, 1986
Yarden Y, Schlessinger J: Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation. Biochemistry 26: 1434–1442, 1987
Gill GN, Lazar CS: Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 293: 305–307, 1981
Wildenhain Y, Pawson T, Blackstein ME, Andrulis IL: p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2. Oncogene 5: 879–883, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mahacek, M.L., Beer, D.G., Frank, T.S. et al. Finite proliferative lifespanin vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Tr 28, 267–276 (1993). https://doi.org/10.1007/BF00666588
Issue Date:
DOI: https://doi.org/10.1007/BF00666588